Multiple Myeloma | Maryland Oncology Hematology Multiple Myeloma – Maryland Oncology Hematology
Clinical Trial Categories

Multiple Myeloma Trials

« Return to Trial Main

Trial ID BGB-11417-105

NCT04973605
clinicaltrials.gov ID
Phase Ib/II
Trial Details

Trial ID 20285

NCT04782687
clinicaltrials.gov ID
USOR ID: 20285 Phase II
A Phase II Trial of Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Combination with Selinexor for Patients with Newly Diagnosed Multiple Myeloma
Trial Details
« Return to Trial Main

Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology